Montero Feijoo A, Maseda E, Adalia Bartolomé R, Aguilar G, González de Castro R, Gómez-Herreras J I, García Palenciano C, Pereira J, Ramasco Rueda F, Samso E, Suárez de la Rica A, Tamayo Medel G, Varela Durán M
Unidad de Cuidados Críticos Quirúrgicos, Servicio de Anestesia, Hospital Universitario La Paz.
Unidad de Cuidados Críticos Quirúrgicos, Servicio de Anestesia, Hospital Universitario La Paz.
Rev Esp Anestesiol Reanim (Engl Ed). 2020 May;67(5):253-260. doi: 10.1016/j.redar.2020.03.003. Epub 2020 Mar 17.
In December 2019, the Wuhan Municipal Health and health Commission (Hubei Province, China) reported a series of cases of pneumonia of unknown etiology. On January 7, 2020, the Chinese authorities identified as a causative agent of the outbreak a new type of virus of the Coronaviridiae family, called SARS-CoV-2. Since then, thounsands of cases have been reported with global dissemination. Infections in humans cause a broad clinical spectrum ranging from mild upper respiratory tract infection, to severe acute respiratory distress syndrome and sepsis. There is not specific treatment for SARS-CoV-2, which is why the fundamental aspects are to establish adequate prevention measures and support treatment and management of complications.
2019年12月，武汉市卫生健康委员会（中国湖北省）报告了一系列病因不明的肺炎病例。2020年1月7日，中国当局确定一种新型冠状病毒（SARS-CoV-2）为此次疫情的病原体。自那时起，全球范围内已报告了数千例病例。人类感染后会出现广泛的临床症状，从轻度上呼吸道感染到严重急性呼吸窘迫综合征和脓毒症。目前尚无针对SARS-CoV-2的特效治疗方法，因此关键在于制定适当的预防措施，并支持对并发症的治疗和管理。
